Meet the Board

Corinne TRUFFAULT President With three decades of experience in the pharmaceutical industry, Corinne Truffault has occupied various Sales & Management positions within the sector. In 2021, Corinne Truffault took a step forward by acquiring the pharmaceutical group Intsel Chimos via an MBO.

Our Values

In addition to the Non-Disclosure Agreement, every project integrated with DIVERCHIM is coded under a unique reference number in order to protect our clients and their molecules’ identities. DIVERCHIM provides services based on its young, motivated and flexible teams of

Medicinal Chemistry

DIVERCHIM supports all your preclinical developments of drug candidates or cosmetic ingredients. Our strengths: A strong expertise for many sorts of APIs (natural products, steroids, alkaloids…) Innovative and responsive scientific teams A recognized experience in hits design and synthesis A

Custom Synthesis

Custom manufacturing of complexe and original molecules represents the core business of DIVERCHIM and its main expertise. DIVERCHIM takes over projects from hundreds of miligrammes up to tens of kilogrammes per batch based on its internal know-how and  all available

Production

Several equipped laboratories with one fully dedicated to cGMP production (clinical phases and recurrent production) for tens of grams Two kilo-labs with one fully dedicated to cGMP production for hundreds of grams to a few kilograms A cGMP pilot plant